IL2 and autoimmune disease: Recently, it was reported that IL-2 bound to a specific monoclonal anti-IL-2 antibody (JES6-1A12) expands CD4+ CD25+ Tregs (106) and protects against various experimental autoimmune diseases as well as rejection of an allogeneic solid organ graft (107–109).